Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
November 12, 2026 4.834
November 11, 2026 5.024
November 10, 2026 4.867
November 09, 2026 4.673
November 06, 2026 4.419
November 05, 2026 4.144
November 04, 2026 4.204
November 03, 2026 4.275
November 02, 2026 3.827
October 30, 2026 4.013
October 29, 2026 4.352
October 28, 2026 4.504
October 27, 2026 4.282
October 26, 2026 4.220
October 23, 2026 4.123
October 22, 2026 4.094
October 21, 2026 4.068
October 20, 2026 4.009
October 19, 2026 3.793
October 16, 2026 3.827
October 15, 2026 3.852
October 14, 2026 3.751
October 13, 2026 3.819
October 12, 2026 4.039
October 09, 2026 4.144
Date Value
October 08, 2026 4.039
October 07, 2026 4.132
October 06, 2026 4.220
October 05, 2026 4.415
October 02, 2026 4.461
October 01, 2026 4.740
September 30, 2026 4.973
September 29, 2026
September 28, 2026
September 25, 2026
September 24, 2026
September 23, 2026
September 22, 2026
September 21, 2026
September 18, 2026
September 17, 2026
September 16, 2026
September 15, 2026
September 14, 2026
September 11, 2026
September 10, 2026
September 09, 2026
September 08, 2026
September 04, 2026
September 03, 2026

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Cellectis SA 3.261
Akari Therapeutics Plc 0.6128
Bicycle Therapeutics Plc 0.4779
EDAP TMS SA 4.480
Autolus Therapeutics Plc 15.43

Price to Book Value Related Metrics

Price 11.43
Earnings Yield -26.44%
Market Cap 718.27M